Acro Biomedical Co (Acro Biomedical Co) Net Change in Cash : $-0.07 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Acro Biomedical Co's Net Change in Cash for the three months ended in Jun. 2023 was $0.00 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.07 Mil.

Acro Biomedical Co Net Change in Cash Historical Data

The historical data trend for Acro Biomedical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Net Change in Cash Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

Net Change in Cash

Get a 7-Day Free Trial

-0.04

0.02

0.08

-0.09

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Net Change in Cash	Get a 7-Day Free Trial															-0.35	-0.05	-0.01	-0.01	-

Acro Biomedical Co Net Change in Cash Calculation

Acro Biomedical Co's Net Change in Cash for the fiscal year that ended in Dec. 2022 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.147	+	0	+	0.058	+	0
	=	-0.09

Acro Biomedical Co's Net Change in Cash for the quarter that ended in Jun. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0.002 + 0 + 0 + 0

= 0.00

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Acro Biomedical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Net Change in Cash

Comparable Companies

AHG COSM ENMI EDAP ZYXI MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739 TSE:9987 SHSE:600056

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines